Current NDC auxiliary source row compounder:702

This page is keyed by dataset, FDA.report source record ID, and physical source row number. Empty values are shown rather than omitted.

Complete normalized row#

Record Source: ndc_compounder_zip
Product Ndc Raw: 81375-259
Product Ndc: 81375-259
Product Ndc Digits: 81375259
Product Type Name: HUMAN COMPOUNDED DRUG
Proprietary Name: Moxifloxacin/Bromfenac
Proprietary Name Suffix: [empty]
Nonproprietary Name: Moxifloxacin 0.5%/Bromfenac 0.09%
Dosage Form Name: SOLUTION/ DROPS
Route Name: OPHTHALMIC
Marketing Category Name: OUTSOURCING FACILITY COMPOUNDED HUMAN DRUG PRODUCT (EXEMPT FROM APPROVAL REQUIREMENTS)
Labeler Name: PQ Pharmacy LLC
Establishment Name: PQ Pharmacy LLC
Establishment Fei: [empty]
Substance Name: MOXIFLOXACIN HYDROCHLORIDE; BROMFENAC SODIUM
Active Ingredients Info: 5 mg/1 mL; .9 mg/1 mL
History Active Ingredients Raw: MOXIFLOXACIN HYDROCHLORIDE; BROMFENAC SODIUM
History Active Ingredients Info Raw: 5 mg/1 mL; .9 mg/1 mL
History Dosage Raw: SOLUTION/ DROPS
Dea Schedule: [empty]
Package Ndc Raw: 81375-259-05
Package Ndc: 81375-259-05
Package Ndc Digits: 8137525905
Package Ndc11: 81375025905
Package Description: 5.6 mL in 1 BOTTLE, DROPPER (81375-259-05)
Reporting Period Raw: 2026-1
Reporting Period: 2026-1
Normalization Status: valid
Source Url: https://www.accessdata.fda.gov/cder/compounders_ndc_directory.zip
Source Archive: compounders_ndc_directory.zip
Source File: compounders_ndc_directory.txt
Source Date: 2026-09-18
Source Last Modified: Fri, 18 Sep 2026 15:17:23 GMT
Source Archive Sha256: 222f6800f79cb1a0fa79431b7226bd6b34899999dbf086af51004a96774ada98
Source Member Sha256: f8d9743e5616579a34d614887e86a53913efa0a63d3138d59d2f87cbb4d0cc17
Source Record Id: compounder:702
Source Row Number: 702
Source Row Hash: 46bc7b8b19cd3c199428c74772d32a6c7c255dcaf327bdd8831983d1fc9332cd
Import Run Id: 20261015T162751Z
Loaded At: 2026-10-15 16:32:20

Exact raw FDA source fields#

{
    "ROUTENAME": "OPHTHALMIC",
    "PRODUCTNDC": "81375-259",
    "DEASCHEDULE": "",
    "LABELERNAME": "PQ Pharmacy LLC",
    "SUBSTANCENAME": "MOXIFLOXACIN HYDROCHLORIDE; BROMFENAC SODIUM",
    "DOSAGEFORMNAME": "SOLUTION/ DROPS",
    "NDCPACKAGECODE": "81375-259-05",
    "PRODUCTTYPENAME": "HUMAN COMPOUNDED DRUG",
    "PROPRIETARYNAME": "Moxifloxacin/Bromfenac",
    "REPORTINGPERIOD": "2026-1",
    "NONPROPRIETARYNAME": "Moxifloxacin 0.5%/Bromfenac 0.09%",
    "PACKAGEDESCRIPTION": "5.6 mL in 1 BOTTLE, DROPPER (81375-259-05) ",
    "ACTIVEINGREDIENTSINFO": "5 mg/1 mL; .9 mg/1 mL",
    "MARKETINGCATEGORYNAME": "OUTSOURCING FACILITY COMPOUNDED HUMAN DRUG PRODUCT (EXEMPT FROM APPROVAL REQUIREMENTS)",
    "PROPRIETARYNAMESUFFIX": ""
}

Normalization notes#

[]

Current status projection#

Dataset: compounder
Record Source: ndc_compounder_zip
Source Record Id: compounder:702
Source Row Number: 702
Status Scope: package
Lookup Ndc: 81375-259-05
Lookup Ndc Digits: 8137525905
Product Ndc: 81375-259
Product Ndc Digits: 81375259
Package Ndc: 81375-259-05
Package Ndc Digits: 8137525905
Package Ndc11: 81375025905
Product Id: [empty]
Status Code: COMPOUNDER
Status Label: Outsourcing facility compounded drug report
Reporting Period Raw: 2026-1
Reporting Period: 2026-1
Source Table: fda_ndc_aux_compounder
Source File: compounders_ndc_directory.txt
Source Date: 2026-09-18
Source Row Hash: 46bc7b8b19cd3c199428c74772d32a6c7c255dcaf327bdd8831983d1fc9332cd
Import Run Id: 20261015T162751Z
Loaded At: 2026-10-15 16:32:20